Your browser doesn't support javascript.
loading
Adaptive immune response to BNT162b2 mRNA vaccine in immunocompromised adolescent patients.
Bader, Guy; Itan, Michal; Edry-Botzer, Liat; Cohen, Hadar; Haskin, Orly; Mozer-Glassberg, Yael; Harel, Liora; Munitz, Ariel; Mandelblit, Nufar Marcus; Gerlic, Motti.
Affiliation
  • Bader G; Department of Clinical Microbiology and Immunology, Sackler School of Medicine Tel Aviv University, Tel Aviv, Israel.
  • Itan M; Department of Clinical Microbiology and Immunology, Sackler School of Medicine Tel Aviv University, Tel Aviv, Israel.
  • Edry-Botzer L; Department of Clinical Microbiology and Immunology, Sackler School of Medicine Tel Aviv University, Tel Aviv, Israel.
  • Cohen H; Department of Clinical Microbiology and Immunology, Sackler School of Medicine Tel Aviv University, Tel Aviv, Israel.
  • Haskin O; Sackler School, Medicine Tel Aviv University, Tel Aviv, Israel.
  • Mozer-Glassberg Y; Nephrology Unit, Schneider Children's Medical Center of Israel, Petach Tikva, Israel.
  • Harel L; Sackler School, Medicine Tel Aviv University, Tel Aviv, Israel.
  • Munitz A; Gastroenterology Unit, Schneider Children's Medical Center of Israel, Petach Tikva, Israel.
  • Mandelblit NM; Sackler School, Medicine Tel Aviv University, Tel Aviv, Israel.
  • Gerlic M; Rheumatology Unit, Schneider Children's Medical Center of Israel, Petach Tikva, Israel.
Front Immunol ; 14: 1131965, 2023.
Article in En | MEDLINE | ID: mdl-37051242
Subject(s)
Key words
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Health context: 1_ASSA2030 / 2_ODS3 / 4_TD Database: MEDLINE Main subject: COVID-19 / BNT162 Vaccine Limits: Adolescent / Adult / Humans Language: En Journal: Front Immunol Year: 2023 Document type: Article
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Health context: 1_ASSA2030 / 2_ODS3 / 4_TD Database: MEDLINE Main subject: COVID-19 / BNT162 Vaccine Limits: Adolescent / Adult / Humans Language: En Journal: Front Immunol Year: 2023 Document type: Article